SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Atezolizumab after multi-modal definitive treatment did not improve outcomes in patients with locally advanced head and neck cancer.
View the guidelines and practice parameters are available for public comment.
Suresh Senan, MRCP, FRCR, PhD, Amsterdam University Medical Centers, Amsterdam, Netherlands, discusses findings from the ADRIATIC study (NCT03703297) of durvalumab consolidation therapy in patients with…
Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of…
PURPOSEThe purpose of our study was to (1) use a large language model (LLM) to identify goals-of-care (GOC) conversations in a large volume of notes,…
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
A group of experts discuss the current treatment algorithm for NSCLC, as well as novel approaches under investigation, the impact of molecular biomarkers on their…
CA: A Cancer Journal for Clinicians publishes information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and…
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number…
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their…